newsfilter
← Latest News
PR Newswire·

Harbour BioMed Reports 2025 Interim Results

Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ...